Related Experiment Video

Updated: Aug 8, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 24, 2014

Immunofluorescence versus ELISA for the detection of antinuclear antigens

Jan M M Rondeel1

  • 1Isala Klinieken, Location Sophia Department of Clinical Chemistry, P.O. Box 10400, 8000 GK Zwolle, The Netherlands. j.rondeel@isala.nl

Expert Review of Molecular Diagnostics
|June 8, 2002
PubMed

Insights

Diagnosing connective tissue disease (CTD) using antinuclear antigen (ANA) tests presents challenges. While ELISA offers automation, its clinical value compared to immunofluorescence (IF) for ANA testing requires careful consideration of selective test ordering.

Area of Science:

  • Immunology
  • Clinical Diagnostics
  • Autoimmune Diseases

Background:

  • Accurate detection of antinuclear antigens (ANA) is crucial for diagnosing connective tissue diseases (CTD).
  • The immunofluorescence technique (IF) has been a traditional method, but enzyme-linked immunosorbent assays (ELISA) are increasingly adopted due to automation potential.
  • Existing comparative literature on IF versus ELISA for ANA testing lacks definitive conclusions regarding performance superiority.

Purpose of the Study:

  • To critically evaluate the clinical utility of immunofluorescence (IF) and enzyme-linked immunosorbent assay (ELISA) for antinuclear antigen (ANA) testing in the diagnostic cascade for connective tissue diseases (CTD).
  • To discuss the technical, logistical, and clinical performance aspects of both IF and ELISA methods for ANA detection.
  • To emphasize the importance of selective test ordering to enhance the predictive value of ANA testing in CTD diagnosis.

Main Methods:

  • Comparative analysis of immunofluorescence (IF) and enzyme-linked immunosorbent assay (ELISA) for antinuclear antigen (ANA) detection.
  • Discussion of technical and logistical factors influencing test selection.
  • Review of clinical value and impact on diagnostic strategies for connective tissue diseases (CTD).

Main Results:

  • ELISA offers advantages in automation and reduced need for specialized expertise compared to IF.
  • Direct comparisons in literature do not provide unequivocal evidence that ELISA consistently outperforms IF in clinical diagnostic accuracy for ANA.
  • The clinical value, rather than solely technical performance, should guide the choice of ANA testing method.

Conclusions:

  • The selection of an appropriate method for antinuclear antigen (ANA) testing in diagnosing connective tissue diseases (CTD) should prioritize clinical utility over technical or logistical benefits alone.
  • Selective test ordering is a key strategy to maximize the predictive value of ANA tests.
  • A balanced consideration of the pros and cons of both immunofluorescence (IF) and ELISA is necessary for optimal diagnostic pathways.

More Related Videos

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies10:16

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies

Published on: September 15, 2016

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate10:05

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Published on: January 17, 2018

Related Concept Videos

Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Immunofluorescence Microscopy01:12

Immunofluorescence Microscopy

A fluorescence microscope uses fluorescent chromophores called fluorochromes, which can absorb energy from a light source and then emit this energy as visible light. Fluorochromes include naturally fluorescent substances (such as chlorophylls) and fluorescent stains that are added to the specimen to create contrast. Dyes such as Texas red and FITC are examples of fluorochromes. Other examples include the nucleic acid dyes 4’,6’-diamidino-2-phenylindole (DAPI), and acridine orange.
The...
Immunocytochemistry and Immunohistochemistry01:22

Immunocytochemistry and Immunohistochemistry

Immunocytochemistry (ICC) and immunohistochemistry (IHC) are techniques that use antibodies to check for specific proteins or antigens in a sample. The technique was first published by Albert Coons in 1941 to detect the presence of pneumococcal antigen in tissue sections from mice infected with Pneumococcus. Immunocytochemistry helps localization of proteins or antigens in individual cells like blood cells, stem cells, etc., while immunohistochemistry does the same for tissue samples.
These...
Immunogold Electron Microscopy01:20

Immunogold Electron Microscopy

Immunoelectron microscopy utilizes immunogold labeling of endogenous proteins with specific antibodies to detect and localize these proteins in cells and tissues. The procedure provides insights into the distribution and quantification of protein under different stimulation conditions offering clues about their functions. Conjugating highly electron-dense gold particles with primary or secondary antibodies allow antigen detection on and within cells, with high resolution and specificity.